ROK Global PLC, the mobile and web technology, services and applications development company, has today announced the successful completion of its first UK trial of ROK Homeland Security (RHS) service with a major insurance company specialising in risk management services.
This follows the successful trials and operational deployments of the RHS service with several law enforcement agencies across the United States.
Commenting, Jonathan Kendrick, Chairman of ROK said “For obvious confidentiality and security reasons we are unable to be specific with regards to the details of this trial, but given the success of RHS in the US, we are delighted to have completed this trial to the complete satisfaction of our partners and we look forward to seeing the commercial deployment of the service in the UK and Europe in the near future.”
RHS, developed by ROK, is a unique mobile phone-based safety, security and policing service which provides real-time, secure technologies to assist in the production, gathering and management of information in a variety of formats including encrypted data-based communications, mapping, tracking and spatial awareness capabilities.
Listed on the Open Market of the Frankfurt Stock Exchange, ROK Global PLC was co-founded by US Billionaire John Paul DeJoria and UK-based serial technology-specialist entrepreneur, Jonathan Kendrick.
In addition to RHS, ROK has pioneered many new and innovative technologies in the rapidly evolving mobile and web space, including high quality mass-market Mobile TV (which can be streamed, live and on-demand, over 2.5G as well as 3G and Wi-Fi) as well as multi-language text-to-speech technologies and innovative online e-commerce solutions.
For more information:
Safe Harbor Statement; The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward- looking statements, including, but not limited to, certain delays beyond the company's control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time.